Fig. 1
From: Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Mean number of subjects in each trial phase for non-orphan and orphan groups. Missing = trial phase information not available
Fig. 1 | Orphanet Journal of Rare Diseases